Cargando…
Compassionate Use of GC5131 (Hyperimmunoglobulin) Therapy in Critically Ill Patients Diagnosed with COVID-19: A Case Series and Review of Literature
Presently, the use of convalescent plasma and hyperimmunoglobulin obtained from individuals who have recovered from coronavirus disease 2019 (COVID-19) has proved to potentially provide passive antibody-based immunity, thereby leading to several clinical trials to develop an immune-based COVID-19 tr...
Autores principales: | Choi, Sunha, Hwang, Soyoon, Kwon, Kitae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473256/ https://www.ncbi.nlm.nih.gov/pubmed/34578407 http://dx.doi.org/10.3390/v13091826 |
Ejemplares similares
-
Cyclic Fevers in Adult Diagnosed As Hyperimmunoglobulin D Syndrome
por: Reji, Merin, et al.
Publicado: (2022) -
Hyperimmunoglobulin E syndrome
por: Ghaffari, Javad
Publicado: (2018) -
Prophylactic Anti-Cytomegalovirus Hyperimmunoglobulin in Critically Ill Liver Transplant Patients: Impact on Early Immunology and Survival
por: Kornberg, Arno, et al.
Publicado: (2020) -
Pediatric hyperimmunoglobulin E syndrome: A case series of 4 children in China
por: Fan, Huifeng, et al.
Publicado: (2018) -
Hyperimmunoglobulin E syndrome in two siblings
por: Hawilo, Abdulmohti, et al.
Publicado: (2011)